U.S. Markets open in 35 hrs, 36 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Day Low 09:34 AM EDT | 2.36 | |
|---|---|---|
| Day High 03:00 PM EDT | 2.40 |
|
| Range | 0.04 | |
| Volume | 160,038 | |
| 30-Day Avg. Vol. | — |
|
| Difference | — | |
| Market Cap. | 370.76 M | |
| Change | 4.65 M | |
| Shares Out. | 142.32 M | |
| Percent Traded | 0.10% | |
| Revenue (LFY) | — | |
| Earnings (TTM) | — | |
| Next Earnings | 11/10/08 |
|
| EPS (TTM) | -0.27 |
| 52-Wk Low 3/17/08 | 0.69 | |
|---|---|---|
| 52-Wk High 7/15/08 | 2.51 |
|
| Range | 1.82 | |
| Prev. Close 9/4/08 | 2.36 | |
| Today's Open | 2.36 | |
| Change | 0.00% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | 4.4048 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Lev Pharmaceuticals wants be a healer for a wide variety of patients. The company is researching a series of drugs to fight inflammatory ailments. Its treatment for angioedema (a skin swelling disorder), ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.055 3/31/08 | -0.06 3/31/08 |
-0.005
Missed
|
| Last Quarter | -0.057 6/30/08 | -0.08 6/30/08 |
-0.023
Missed
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
